Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

rTMS Posterior Parietal Cortex Modulation and Upper Limb Movement After Stroke

NCT: NCT03323255 · TERMINATED

NCT IDNCT03323255
StatusTERMINATED
Start Date2020-03-10
Completion2021-08-01

Brief Summary

This study evaluates the effect of a unique session of inhibitory rTMS (cTBS) over the contralesional posterio parietal cortex (PPC) on the spatio-temporal parameters of a pointing movement performed by stroke patients with their paretic upper limb. It will also assess the effects on the resting motor threshold of both hemispheres and on parietopremotor connectivity. To achieve theses aims, the real cTBS stimulation will be randomly counterbalanced with a SHAM stimulation (in a second session) in a crossover design. Assessments will be performed before and after each stimulation session.

Frequently Asked Questions

What is rTMS Posterior Parietal Cortex Modulation and Upper Limb Movement After Stroke?

rTMS Posterior Parietal Cortex Modulation and Upper Limb Movement After Stroke is a clinical trial registered under NCT03323255. Current status: TERMINATED.

What is the status of NCT03323255?

The current status of NCT03323255 (rTMS Posterior Parietal Cortex Modulation and Upper Limb Movement After Stroke) is: TERMINATED.

When did rTMS Posterior Parietal Cortex Modulation and Upper Limb Movement After Stroke start?

rTMS Posterior Parietal Cortex Modulation and Upper Limb Movement After Stroke started on 2020-03-10.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.